Advanced Search

Anesthesia Coding Alert

DRUG WARNING ~ FDA Releases Alert on Using Methadone for Pain Mgmt

Published on Tue Jan 16, 2007

Click to read the full warning The FDA recently released a warning on methadone used for pain management services. An excerpt from the release reads:

"FDA has reviewed reports of death and life-threatening adverse events such as respiratory depression and cardiac arrhythmias in patients receiving methadone. These adverse effects are the possible result of unintentional methadone overdoses, drug interactions and methadone's cardiac toxicities. ... Physicians prescribing methadone should be familiar with methadone's toxicities and unique pharmaceutical properties. Methadone's elimination half-life (8-59 hours) is longer than its duration of analgesic action (4-8 hours). ... Physicians should closely monitor patients when converting them from other opioids and changing the methadone dose, and thoroughly instruct the patients how to take methadone."

To read the complete release, visit the FDA site www.fda.gov/cder/drug/InfoSheets/HCP/methadoneHCP.pdf.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Anesthesia Coding Alert

View All